Abciximab - HY-P9934
Nur noch %1 verfügbar
Catalog #
HY-P9934
Ab
256,00 €
Abciximab (C7E3), a chimeric mouse/human monoclonal antibody, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P9934/Abciximab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Dry Ice |
| Application | Neuroscience-Neuromodulation |
| Alternative Names | C7E3 |
| CAS | 143653-53-6 |
| Storage | Store at -80°C for 2 years |
| MWT | N/A |
| Solubility | H2O |
| Clinical Information | Launched |
| Pathway | Cytoskeleton |
| Target | Integrin |
| Application: | Neuroscience-Neuromodulation |
|---|